Mayne Pharma | MYX - Gross Profit On Sales

Stock Price
2.81
Daily Change
0.12 4.46%
Monthly
19.57%
Yearly
-60.03%
Q2 Forecast
2.52

Mayne Pharma reported AUD86.13M in Gross Profit on Sales for its fiscal semester ending in June of 2025.





Gross Profit On Sales Change Date
Ansell USD 326.2M 27.6M Jun/2024
Avita Medical AUD 14.31M 639K Dec/2025
Cochlear AUD 856.8M 430M Dec/2025
CSL USD 4.46B 2.71B Dec/2025
Healius AUD 554.4M 415.55M Dec/2024
Integral Diagnostics AUD 226.91M 7.04M Jun/2024
Medical Developments International AUD 7.35M 7.37M Jun/2025
Nanosonics AUD 78.01M 3.95M Dec/2025
Polynovo AUD 61.26M 38M Dec/2025
Ramsay Health Care AUD 549.95M 5.77B Jun/2025
ResMed USD 886.53M 65.71M Dec/2025
Sigma Healthcare AUD 160.13M 10.55M Jul/2024
Sonic Healthcare AUD 3.92B 3.14B Dec/2024
Telix Pharmaceuticals AUD 217.82M 9.23M Dec/2025